Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
2
33%
Ph early_phase_1
1
17%
Ph phase_4
1
17%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Recruiting2
Completed2
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

unknown117%
recruiting233%
completed233%
terminated117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
6